CANbridge Life Sciences
Bio-pharmaceutical company accelerating development and commercialization of specialty healthcare.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD668m (Public information from Dec 2020)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$10.0m | Series A | ||
$10.0m | Series A | ||
$25.0m | Series B | ||
$38.1m | Series C | ||
* | $98.0m | Series D | |
$43.0m Valuation: $490m | Series E | ||
* | N/A | $77.0m | IPO |
Total Funding | CAD306m |
Recent News about CANbridge Life Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.